Post-earnings recap
Reported
Thu, Jul 31, 2025
EPS actual
$2.97
EPS est.
$3.24
EPS surprise
-8.39%
1-day move
-0.15%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
AbbVie's earnings report shows a miss on EPS, which may raise concerns among investors about the company's profitability. The stock reacted slightly down by 0.15%, indicating a muted response to the results. Without additional guidance or commentary from management, it remains unclear how the company plans to address these challenges moving forward.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.97 | N/A | -8.39% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based solely on numerical results.